# Vistagen Therapeutics, Inc.: Form 8-K, filed Sep 11, 2026

- Company: [Vistagen Therapeutics, Inc.](/companies/vtgn.md) (CIK 1411685)
- Form: 8-K
- Filed: 2026-09-11
- Accepted by EDGAR: Sep 10, 2026, 19:24 ET
- Period: 2026-09-10
- Accession: 0001628280-26-061445
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/vtgn-20260910.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/vtgn-20260910.htm

Filed Sep 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-061445. Last ingested by Listed: Oct 30, 2026, 17:32 ET. No prices; not investment advice.